Observational analysis reveals reduced dementia risk in atrial fibrillation patients receiving catheter ablation, highlighting the critical role of optimized anticoagulation.
Atrial fibrillation (AF) is associated with the development of dementia, and observational studies have shown that oral anticoagulation and catheter ablation reduce dementia risk. However, such studies did not consistently report on periprocedural anticoagulation and long-term oral anticoagulation coverage, for which reason the separate effect of AF ablation on dementia risk could not be established.
No takes yet. Share an insight, caveat, or question.
Åkerström et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: